Growth hormone and IGF-1 deficiency exacerbate high-fat diet-induced endothelial impairment in obese lewis dwarf rats: Implications for vascular aging

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 67 A, Issue 6, 2012, Pages 553-564

  Bailey Downs, Lora C ^a,b   Sosnowska, Danuta ^a   Toth, Peter ^a   Mitschelen, Matthew ^a   Gautam, Tripti ^a   Henthorn, Jim C ^a   Ballabh, Praveen ^c   Koller, Akos ^d,e   Farley, Julie A ^a   Sonntag, William E ^a   Csiszar, Anna ^a   Ungvari, Zoltan ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c New York Medical College ^*  (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Accelerated aging; Endothelial dysfunction; IGF 1; Obesity; Vascular pathophysiology

Indexed keywords

RATTUS;

CYTOKINE; GROWTH HORMONE; INSULIN; INSULIN LIKE GROWTH FACTOR 1, RAT; INSULIN-LIKE GROWTH FACTOR-1, RAT; INTERCELLULAR ADHESION MOLECULE 1; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; AORTA; ARTICLE; BIOSYNTHESIS; BLOOD; DWARFISM; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; LEWIS RAT; LIPID DIET; MALE; METABOLISM; OBESITY; OXIDATIVE STRESS; RAT;

ANIMALS; AORTA; BLOOD GLUCOSE; CYTOKINES; DIET, HIGH-FAT; DWARFISM; GLUCOSE TOLERANCE TEST; GROWTH HORMONE; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INTERCELLULAR ADHESION MOLECULE-1; MALE; OBESITY; OXIDATIVE STRESS; RATS; RATS, INBRED LEW; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861059895     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glr197     Document Type: Article

References (88)

1. Fantuzzi G, Mazzone T. Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol. 2007;27:996-1003. (Pubitemid 46641984)
2. Osher E, Stern N. Obesity in elderly subjects: in sheep's clothing perhaps, but still a wolf! Diabetes Care. 2009;32(suppl 2):S398-S402.
3. Rimm EB, Stampfer MJ, Giovannucci E, et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older us men. Am J Epidemiol. 1995;141:1117-1127.
4. Ungvari Z, Kaley G, de Cabo R, Sonntag WE, Csiszar A. Mechanisms of vascular aging: new perspectives. J Gerontol A Biol Sci Med Sci. 2010;65:1028-1041.
5. Ungvari Z, Bailey-Downs L, Gautam T, et al. Age-associated vascular oxidative stress, nrf2 dysfunction and nf-kb activation in the non-human primate macaca mulatta. J Gerontol A Biol Sci Med Sci. 2011;66:866-875.
6. Ungvari Z, Bailey-Downs L, Sosnowska D, et al. Vascular oxidative stress in aging: a homeostatic failure due to dysregulation of nrf2-mediated antioxidant response. Am J Physiol Heart Circ Physiol. 2011;301(2):H363-H372.
7. Collins AR, Lyon CJ, Xia X, et al. Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes. Circ Res. 2009;104:e42-e54.
8. Breese CR, Ingram RL, Sonntag WE. Influence of age and long-term dietary restriction on plasma insulin-like growth factor-1 (IGF-1), IGF-1 gene expression, and IGF-1 binding proteins. J Gerontol. 1991;46:B180-B187.
9. D'Costa AP, Ingram RL, Lenham JE, Sonntag WE. The regulation and mechanisms of action of growth hormone and insulin-like growth factor 1 during normal ageing. J Reprod Fertil (Suppl.). 1993;46:87-98.
10. Khan AS, Sane DC, Wannenburg T, Sonntag WE. Growth hormone, insulin-like growth factor-1 and the aging cardiovascular system. Cardiovasc Res. 2002;54:25-35.
11. Evans LM, Davies JS, Goodfellow J, Rees JA, Scanlon MF. Endothelial dysfunction in hypopituitary adults with growth hormone deficiency. Clin Endocrinol (Oxf). 1999;50:457-464. (Pubitemid 29193228)
12. Denti L, Annoni V, Cattadori E, et al. Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly. Am J Med. 2004;117:312-317. (Pubitemid 39164563)
13. Oflaz H, Sen F, Elitok A, et al. Coronary flow reserve is impaired in patients with adult growth hormone (GH) deficiency. Clin Endocrinol (Oxf). 2007;66:524-529. (Pubitemid 46434934)
14. Vasan RS, Sullivan LM, D'Agostino RB, et al. Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann Intern Med. 2003;139:642-648.
15. Roubenoff R, Parise H, Payette HA, et al. Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am J Med. 2003;115:429-435. (Pubitemid 37237554)
16. Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab. 2004;89:114-120. (Pubitemid 38183869)
17. Kaplan RC, McGinn AP, Pollak MN, et al. High insulinlike growth factor binding protein 1 level predicts incident congestive heart failure in the elderly. Am Heart J. 2008;155:1006-1012.
18. Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990;336:285-288. (Pubitemid 20229130)
19. Bates AS, Van't Hoff W, Jones PJ, Clayton RN. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab. 1996;81:1169-1172. (Pubitemid 26083989)
20. Bulow B, Hagmar L, Mikoczy Z, Nordstrom CH, Erfurth EM. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol. 1997;46:75-81. (Pubitemid 27072849)
21. Tomlinson JW, Holden N, Hills RK, et al. Association between premature mortality and hypopituitarism. West midlands prospective hypopituitary study group. Lancet. 2001;357:425-431.
22. Forman K, Vara E, Garcia C, et al. Effect of a combined treatment with growth hormone and melatonin in the cardiological aging on male samp8 mice. J Gerontol A Biol Sci Med Sci. 2001;66A(8):823-834.
23. Higashi Y, Sukhanov S, Anwar A, Shai SY, Delafontaine P. IGF-1, oxidative stress and atheroprotection. Trends Endocrinol Metab. 2010;21:245-254.
24. Sukhanov S, Higashi Y, Shai SY, et al. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2007;27:2684-2690. (Pubitemid 350158923)
25. Ungvari Z, Gautam T, Koncz P, et al. Vasoprotective effects of life span-extending peripubertal GH replacement in Lewis dwarf rats. J Gerontol A Biol Sci Med Sci. 2010;65:1145-1156.
26. Csiszar A, Labinskyy N, Perez V, et al. Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice. Am J Physiol Heart Circ Physiol. 2008;295:H1882-H1894.
27. Bailey-Downs LC, Mitschelen M, Sosnowska D, et al. Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the nrf2-dependent antioxidant response: a novel model of vascular aging. J Gerontol A Biol Sci Med Sci. 2011. doi:10.1093/gerona/GLR164
28. Mitschelen M, Yan H, Farley JA, et al. Long-term deficiency of circulating and hippocampal insulin-like growth factor I induces depressive behavior in adult mice: a potential model of geriatric depression. Neuroscience. 2011;185:50-60.
29. Lichtenwalner RJ, Forbes ME, Sonntag WE, Riddle DR. Adult-onset deficiency in growth hormone and insulin-like growth factor-I decreases survival of dentate granule neurons: insights into the regulation of adult hippocampal neurogenesis. J Neurosci Res. 2006;83:199-210. (Pubitemid 43184384)
30. Ramsey MM, Ingram RL, Cashion AB, et al. Growth hormone-deficient dwarf animals are resistant to dimethylbenzanthracine (dmba)-induced mammary carcinogenesis. Endocrinology. 2002;143:4139-4142. (Pubitemid 35244394)
31. Ungvari Z, Sosnowska D, Podlutsky A, Koncz P, Sonntag WE, Csiszar A. Free radical production, antioxidant capacity, and oxidative stress response signatures in fibroblasts from Lewis dwarf rats: effects of life span-extending peripubertal GH treatment. J Gerontol A Biol Sci Med Sci. 2011;66A(5):501-510.
32. Ungvari ZI, Bailey-Downs L, Gautam T, et al. Adaptive induction of nf-e2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia. Am J Physiol Heart Circ Physiol. 2011;300:H1133-H1140.
33. Pearson KJ, Baur JA, Lewis KN, et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 2008;8:157-168.
34. Ungvari Z, Bagi Z, Feher A, et al. Resveratrol confers endothelial protection via activation of the antioxidant transcription factor nrf2. Am J Physiol Heart Circ Physiol. 2010;299:H18-H24.
35. Charlton HM, Clark RG, Robinson IC, et al. Growth hormone-deficient dwarfism in the rat: a new mutation. J Endocrinol. 1988;119:51-58.
36. Carter CS, Ramsey MM, Ingram RL, et al. Models of growth hormone and IGF-1 deficiency: applications to studies of aging processes and life-span determination. J Gerontol A Biol Sci Med Sci. 2002;57:B177-B188. (Pubitemid 34464960)
37. Carter CS, Ramsey MM, Sonntag WE. A critical analysis of the role of growth hormone and IGF-1 in aging and lifespan. Trends Genet. 2002;18:295-301. (Pubitemid 34607119)
38. Hua K, Forbes ME, Lichtenwalner RJ, Sonntag WE, Riddle DR. Adult-onset deficiency in growth hormone and insulin-like growth factor-I alters oligodendrocyte turnover in the corpus callosum. Glia. 2009;57(10):1062-1071.
39. Nieves-Martinez E, Sonntag WE, Wilson A, et al. Early-onset GH deficiency results in spatial memory impairment in mid-life and is prevented by GH supplementation. J Endocrinol. 2010;204:31-36.
40. Kizer JR, Arnold AM, Jenny NS, et al. Longitudinal changes in adiponectin and inflammatory markers and relation to survival in the oldest old: the cardiovascular health study all stars study. J Gerontol A Biol Sci Med Sci. 2011;66A(10):1100-1107.
41. Kizer JR, Arnold AM, Strotmeyer ES, et al. Change in circulating adiponectin in advanced old age: determinants and impact on physical function and mortality. The cardiovascular health study all stars study. J Gerontol A Biol Sci Med Sci. 2010;65:1208-1214.
42. Csiszar A, Labinskyy N, Orosz Z, Xiangmin Z, Buffenstein R, Ungvari Z. Vascular aging in the longest-living rodent, the naked mole rat. Am J Physiol. 2007;293:H919-H927. (Pubitemid 47254187)
43. Ungvari Z, Csiszar A, Huang A, Kaminski PM, Wolin MS, Koller A. High pressure induces superoxide production in isolated arteries via protein kinase c-dependent activation of nad(p)h oxidase. Circulation. 2003;108:1253-1258. (Pubitemid 37099996)
44. Csiszar A, Ungvari Z, Edwards JG, et al. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res. 2002;90:1159-1166. (Pubitemid 34786900)
45. Csiszar A, Labinskyy N, Smith K, Rivera A, Orosz Z, Ungvari Z. Vasculoprotective effects of anti-tnfalfa treatment in aging. Am J Pathol. 2007;170:388-698.
46. Ungvari ZI, Labinskyy N, Gupte SA, Chander PN, Edwards JG, Csiszar A. Dysregulation of mitochondrial biogenesis in vascular endothelial and smooth muscle cells of aged rats. Am J Physiol Heart Circ Physiol. 2008;294:H2121- H2128.
47. Ungvari ZI, Orosz Z, Labinskyy N, et al. Increased mitochondrial h2o2 production promotes endothelial nf-kb activation in aged rat arteries. Am J Physiol Heart Circ Physiol. 2007;293:H37-H47. (Pubitemid 47108162)
48. Csiszar A, Smith K, Labinskyy N, Orosz Z, Rivera A, Ungvari Z. Resveratrol attenuates tnf-{alpha}-induced activation of coronary arterial endothelial cells: role of nf-{kappa}b inhibition. Am J Physiol. 2006;291:H1694-H1699. (Pubitemid 44497674)
49. Behrens MI, Silva M, Schmied A, et al. Age-dependent increases in apoptosis/necrosis ratios in human lymphocytes exposed to oxidative stress. J Gerontol A Biol Sci Med Sci. 2011;66:732-740.
50. Chandrashekara KT, Shakarad MN. Aloe vera or resveratrol supplementation in larval diet delays adult aging in the fruit fly, Drosophila melanogaster. J Gerontol A Biol Sci Med Sci. 2011;66:965-971.
51. Chung E, Diffee GM. Effect of aging on power output properties in rat skinned cardiac myocytes. J Gerontol A Biol Sci Med Sci. 2011;66A(12):1267-1273.
52. Dekker P, de Lange MJ, Dirks RW, et al. Relation between maximum replicative capacity and oxidative stress-induced responses in human skin fibroblasts in vitro. J Gerontol A Biol Sci Med Sci. 2011;66:45-50.
53. Endt H, Sprung CN, Keller U, Gaipl U, Fietkau R, Distel LV. Detailed analysis of DNA repair and senescence marker kinetics over the life span of a human fibroblast cell line. J Gerontol A Biol Sci Med Sci. 2011;66:367-375.
54. Gunin AG, Kornilova NK, Vasilieva OV, Petrov VV. Age-related changes in proliferation, the numbers of mast cells, eosinophils, and cd45-positive cells in human dermis. J Gerontol A Biol Sci Med Sci. 2011;66:385-392.
55. McFarlane D, Wolf RF, McDaniel KA, White GL. Age-associated alteration in innate immune response in captive baboons. J Gerontol A Biol Sci Med Sci. 2011;66A(12):1309-1317.
56. Sloane LB, Stout JT, Vandenbergh DJ, Vogler GP, Gerhard GS, McClearn GE. Quantitative trait loci analysis of tail tendon break time in mice of c57bl/6j and dba/2j lineage. J Gerontol A Biol Sci Med Sci. 2011;66:170-178.
57. Smith DL Jr., Mattison JA, Desmond RA, et al. Telomere dynamics in rhesus monkeys: no apparent effect of caloric restriction. J Gerontol A Biol Sci Med Sci. 2011;66A(11):1163-1168.
58. Zhu M, Hu J, Perez E, et al. Effects of long-term cranberry supplementation on endocrine pancreas in aging rats. J Gerontol A Biol Sci Med Sci. 2011;66A(11):1139-1151.
59. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419. (Pubitemid 15018832)
60. Sonntag WE, Carter CS, Ikeno Y, et al. Adult-onset growth hormone and insulin-like growth factor I deficiency reduces neoplastic disease, modifies age-related pathology, and increases life span. Endocrinology. 2005;146:2920-2932. (Pubitemid 41002799)
61. Grill JD, Sonntag WE, Riddle DR. Dendritic stability in a model of adult-onset IGF-I deficiency. Growth Horm IGF Res. 2005;15:337-348. (Pubitemid 41403768)
62. Berryman DE, List EO, Sackmann-Sala L, Lubbers E, Munn R, Kopchick JJ. Growth hormone and adipose tissue: Beyond the adipocyte. Growth Horm IGF Res. 2011;21:113-123.
63. Dominici FP, Hauck S, Argentino DP, Bartke A, Turyn D. Increased insulin sensitivity and upregulation of insulin receptor, insulin receptor substrate (irs)-1 and irs-2 in liver of Ames dwarf mice. J Endocrinol. 2002;173:81-94. (Pubitemid 34428894)
64. Davidson MB. Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev. 1987;8:115-131.
65. Borg KE, Brown-Borg HM, Bartke A. Assessment of the primary adrenal cortical and pancreatic hormone basal levels in relation to plasma glucose and age in the unstressed Ames dwarf mouse. Proc Soc Exp Biol Med. 1995;210:126-133.
66. Wang Z, Al-Regaiey KA, Masternak MM, Bartke A. Adipocytokines and lipid levels in Ames dwarf and calorie-restricted mice. J Gerontol A Biol Sci Med Sci. 2006;61:323-331.
67. Louis A, Bartke A, Masternak MM. Effects of growth hormone and thyroxine replacement therapy on insulin signaling in Ames dwarf mice. J Gerontol A Biol Sci Med Sci. 2010;65:344-352.
68. Masternak MM, Panici JA, Wang F, Wang Z, Spong A. The effects of growth hormone (GH) treatment on GH and insulin/IGF-1 signaling in long-lived Ames dwarf mice. J Gerontol A Biol Sci Med Sci. 2010;65:24-30.
69. Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med. 2011;3:70ra13.
70. Wu Y, Liu C, Sun H, et al. Growth hormone receptor regulates beta cell hyperplasia and glucose-stimulated insulin secretion in obese mice. J Clin Invest. 2011;121:2422-2426.
71. Lopez-Siguero JP, Lopez-Canti LF, Espino R, et al. Effect of recombinant growth hormone on leptin, adiponectin, resistin, interleukin-6, tumor necrosis factor-alpha and ghrelin levels in growth hormone-deficient children. J Endocrinol Invest. 2011;34:300-306.
72. Andersson B, Carlsson LM, Carlsson B, Albertsson-Wikland K, Bjarnason R. Decrease in adiponectin levels correlates to growth response in growth hormone-treated children. Horm Res. 2009;71:213-218.
73. Arumugam R, Fleenor D, Freemark M. Effects of lactogen resistance and GH deficiency on mouse metabolism: pancreatic hormones, adipocytokines, and expression of adiponectin and insulin receptors. Endocrine. 2007;32:182-191.
74. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337-342. (Pubitemid 44764104)
75. Lee JH, Bullen JW Jr., Stoyneva VL, Mantzoros CS. Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia. Am J Physiol Endocrinol Metab. 2005;288:E625-E632. (Pubitemid 40250559)
76. Cano P, Cardinali DP, Rios-Lugo MJ, Fernandez-Mateos MP, Reyes Toso CF, Esquifino AI. Effect of a high-fat diet on 24-hour pattern of circulating adipocytokines in rats. Obesity (Silver Spring). 2009;17:1866-1871.
77. Mullen KL, Pritchard J, Ritchie I, et al. Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats. Am J Physiol Regul Integr Comp Physiol. 2009;296:R243-R251.
78. Hecker PA, O'Shea KM, Galvao TF, Brown BH, Stanley WC. Role of adiponectin in the development of high fat diet-induced metabolic abnormalities in mice. Horm Metab Res. 2011;43:100-105.
79. Wu Y, Brodt P, Sun H, et al. Insulin-like growth factor-I regulates the liver microenvironment in obese mice and promotes liver metastasis. Cancer Res. 2010;70:57-67.
80. Molnar J, Yu S, Mzhavia N, Pau C, Chereshnev I, Dansky HM. Diabetes induces endothelial dysfunction but does not increase neointimal formation in high-fat diet fed c57bl/6j mice. Circ Res. 2005;96:1178-1184. (Pubitemid 40827693)
81. Smith JC, Evans LM, Wilkinson I, et al. Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study. Clin Endocrinol (Oxf). 2002;56:493-501. (Pubitemid 34429624)
82. Evans LM, Davies JS, Anderson RA, et al. The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency. Eur J Endocrinol. 2000;142:254-262.
83. Ikeno Y, Bronson RT, Hubbard GB, Lee S, Bartke A. Delayed occurrence of fatal neoplastic diseases in Ames dwarf mice: correlation to extended longevity. J Gerontol A Biol Sci Med Sci. 2003;58:291-296. (Pubitemid 36397045)
84. Forman K, Vara E, Garcia C, Ariznavarreta C, Escames G, Tresguerres JA. Cardiological aging in sam model: effect of chronic treatment with growth hormone. Biogerontology. 2010;11(3):275-286.
85. Csiszar A, Ungvari Z, Koller A, Edwards JG, Kaley G. Aging-induced proinflammatory shift in cytokine expression profile in rat coronary arteries. FASEB J. 2003;17:1183-1185.
86. Csiszar A, Ungvari Z, Koller A, Edwards JG, Kaley G. Proinflammatory phenotype of coronary arteries promotes endothelial apoptosis in aging. Physiol Genomics. 2004;17:21-30. (Pubitemid 38924147)
87. Shai SY, Sukhanov S, Higashi Y, Vaughn C, Rosen CJ, Delafontaine P. Low circulating insulin-like growth factor I increases atherosclerosis in ApoE-deficient mice. Am J Physiol Heart Circ Physiol. 2011;300(5):H1898-H1906.
88. Thorner MO. Statement by the growth hormone research society on the GH/IGF-I axis in extending health span. J Gerontol A Biol Sci Med Sci. 2009;64:1039-1044.